Cellular Immune Reconstitution and Its Impact on Clinical Outcome in Children with β Thalassemia Major Undergoing a Matched Related Myeloablative Allogeneic Bone Marrow Transplant

Biology of Blood and Marrow Transplantation

Volumn 15, Issue 5, 2009, Pages 597-609

  Rajasekar, Reena ^a   Mathews, Vikram ^a   Lakshmi, Kavitha M ^a   George, Biju ^a   Viswabandya, Auro ^a   Chandy, Mammen ^a   Srivastava, Alok ^a  

^a CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

Bone marrow transplantation; Graft rejection; Immune reconstitution; NK cell reconstitution; Thalassemia major

Indexed keywords

ACICLOVIR; BUSULFAN; CD34 ANTIGEN; CD8 ANTIGEN; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; FLUDARABINE; LYMPHOCYTE ANTIBODY; METHOTREXATE; METHYLPREDNISOLONE; PENICILLIN G; THYMOCYTE ANTIBODY;

ADOLESCENT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; BACTERIAL INFECTION; BLOOD SAMPLING; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; EVENT FREE SURVIVAL; FEMALE; GRAFT RECIPIENT; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HLA MATCHING; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MYCOSIS; MYELOABLATIVE CONDITIONING; NATURAL KILLER T CELL; OVERALL SURVIVAL; PROSPECTIVE STUDY; THALASSEMIA MAJOR; TREATMENT OUTCOME;

ADOLESCENT; BETA-THALASSEMIA; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; FEMALE; GRAFT SURVIVAL; GRAFT VS HOST DISEASE; HISTOCOMPATIBILITY; HUMANS; IMMUNE SYSTEM; KINETICS; LYMPHOCYTE COUNT; MALE; MYELOABLATIVE AGONISTS; OPPORTUNISTIC INFECTIONS; REGENERATION; SURVIVAL ANALYSIS; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 63749091360     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2009.01.016     Document Type: Article

References (39)

1. Kalwak K., Gorczynska E., Toporski J., et al. Immune reconstitution after haematopoietic cell transplantation in children: immunophenotype analysis with regard to factors affecting the speed of recovery. Br J Haematol 118 (2002) 74-89
2. Auletta J.J., and Lazarus H.M. Immune restoration following hematopoietic stem cell transplantation: an evolving target. Bone Marrow Transplant 35 (2005) 835-857
3. Reddy V., Iturraspe J.A., Tzolas A.C., Meier-Kriesche H.U., Schold J., and Wingard J.R. Low dendritic cell count after allogeneic hematopoietic stem cell transplantation predicts relapse, death, and acute graft-versus-host disease. Blood 103 (2004) 4330-4335
4. Rajasekar R., Mathews V., Lakshmi K.M., et al. Plasmacytoid dendritic cell count on day 28 in HLA-matched related allogeneic peripheral blood stem cell transplant predicts the incidence of acute and chronic GVHD. Biol Blood Marrow Transplant 14 (2008) 344-350
5. Kim D.H., Sohn S.K., Won D.I., Lee N.Y., Suh J.S., and Lee K.B. Rapid helper T-cell recovery above 200 × 10 6/l at 3 months correlates to successful transplant outcomes after allogeneic stem cell transplantation. Bone Marrow Transplant 37 (2006) 1119-1128
6. Savani B.N., Mielke S., Rezvani K., et al. Absolute lymphocyte count on day 30 is a surrogate for robust hematopoietic recovery and strongly predicts outcome after T cell-depleted allogeneic stem cell transplantation. Biol Blood Marrow Transplant 13 (2007) 1216-1223
7. Berger M., Figari O., Bruno B., et al. Lymphocyte subsets recovery following allogeneic bone marrow transplantation (BMT): CD4+ cell count and transplant-related mortality. Bone Marrow Transplant 41 (2008) 55-62
8. Storek J., Witherspoon R.P., and Storb R. T cell reconstitution after bone marrow transplantation into adult patients does not resemble T cell development in early life. Bone Marrow Transplant 16 (1995) 413-425
9. Kook H., Goldman F., Padley D., et al. Reconstruction of the immune system after unrelated or partially matched T-cell-depleted bone marrow transplantation in children: immunophenotypic analysis and factors affecting the speed of recovery. Blood 88 (1996) 1089-1097
10. Passweg J.R., Stern M., Koehl U., Uharek L., and Tichelli A. Use of natural killer cells in hematopoietic stem cell transplantation. Bone Marrow Transplant 35 (2005) 637-643
11. Passweg J.R., Koehl U., Uharek L., Meyer-Monard S., and Tichelli A. Natural-killer-cell-based treatment in haematopoietic stem-cell transplantation. Best Pract Res Clin Haematol 19 (2006) 811-824
12. Ruggeri L., Capanni M., Martelli M.F., and Velardi A. Cellular therapy: exploiting NK cell alloreactivity in transplantation. Curr Opin Haematol 8 (2001) 355-359
13. Savani B.N., Mielke S., Adams S., et al. Rapid natural killer cell recovery determines outcome after T-cell-depleted HLA-identical stem cell transplantation in patients with myeloid leukemias but not with acute lymphoblastic leukemia. Leukemia 21 (2007) 2145-2152
14. Lucarelli G., Clift R.A., Galimberti M., et al. Marrow transplantation for patients with thalassemia: results in class 3 patients. Blood 87 (1996) 2082-2088
15. Chandy M., Balasubramanian P., Ramachandran S.V., et al. Randomized trial of two different conditioning regimens for bone marrow transplantation in thalassemia-the role of busulfan pharmacokinetics in determining outcome. Bone Marrow Transplant 36 (2005) 839-845
16. Vakkila J., Thomson A.W., Hovi L., Vettenranta K., and Saarinen-Pihkala U.M. Circulating dendritic cell subset levels after allogeneic stem cell transplantation in children correlate with time post transplant and severity of acute graft-versus-host disease. Bone Marrow Transplant 35 (2005) 501-507
17. Sutherland D.R., Anderson L., Keeney M., Nayar R., and Chin-Yee I. The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering. J Hematother 5 (1996) 213-226
18. Glucksberg H., Storb R., Fefer A., et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 18 (1974) 295-304
19. Jabbour E., Rondon G., Anderlini P., et al. Treatment of donor graft failure with nonmyeloablative conditioning of fludarabine, antithymocyte globulin and a second allogeneic hematopoietic transplantation. Bone Marrow Transplant 40 (2007) 431-435
20. Lucarelli G., Galimberti M., Polchi P., et al. Bone marrow transplantation in patients with thalassemia. N Engl J Med 322 (1990) 417-421
21. Mathews V., George B., Deotare U., et al. A new stratification strategy that identifies a subset of class III patients with an adverse prognosis among children with beta thalassemia major undergoing a matched related allogeneic stem cell transplantation. Biol Blood Marrow Transplant 13 (2007) 889-894
22. Guo H., Qiao Z., Su L., Zhu L., Wang H., and Ma L. Analysis of immune reconstitution in adults undergoing non-myeloablative allogeneic peripheral blood stem cell transplantation. Haematologica 88 (2003) 833-835
23. Schulenburg A., Watkins-Riedel T., Greinix H.T., et al. CMV monitoring after peripheral blood stem cell and bone marrow transplantation by pp65 antigen and quantitative PCR. Bone Marrow Transplant 28 (2001) 765-768
24. Ascioglu S., Rex J.H., de Pauw B., et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 34 (2002) 7-14
25. Matthews J.N., Altman D.G., Campbell M.J., and Royston P. Analysis of serial measurements in medical research. BMJ 300 (1990) 230-235
26. Comans-Bitter W.M., de Groot R., van den Beemd R., et al. Immunophenotyping of blood lymphocytes in childhood. Reference values for lymphocyte subpopulations. J Pediatr 130 (1997) 388-393
27. Ikinciogullari A., Kendirli T., Dogu F., et al. Peripheral blood lymphocyte subsets in healthy Turkish children. Turk J Pediatr 46 (2004) 125-130
28. Noel D.R., Witherspoon R.P., Storb R., et al. Does graft-versus-host disease influence the tempo of immunologic recovery after allogeneic human marrow transplantation? An observation on 56 long-term survivors. Blood 51 (1978) 1087-1105
29. Storek J., Dawson M.A., Storer B., et al. Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation. Blood 97 (2001) 3380-3389
30. Voehringer D., Blaser C., Brawand P., Raulet D.H., Hanke T., and Pircher H. Viral infections induce abundant numbers of senescent CD8 T cells. J Immunol 167 (2001) 4838-4843
31. Azuma E., Hirayama M., Yamamoto H., and Komada Y. The role of donor age in naive T-cell recovery following allogeneic hematopoietic stem cell transplantation: the younger the better. Leuk Lymphoma 43 (2002) 735-739
32. Mackall C.L., Fleisher T.A., Brown M.R., et al. Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy. N Engl J Med 332 (1995) 143-149
33. Fagnoni F.F., Oliviero B., Giorgiani G., et al. Reconstitution dynamics of plasmacytoid and myeloid dendritic cell precursors after allogeneic myeloablative hematopoietic stem cell transplantation. Blood 104 (2004) 281-289
34. Bittencourt H., Rocha V., Chevret S., et al. Association of CD34 cell dose with hematopoietic recovery, infections, and other outcomes after HLA-identical sibling bone marrow transplantation. Blood 99 (2002) 2726-2733
35. Ruggeri L., Capanni M., Urbani E., et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 295 (2002) 2097-2100
36. Yamasaki S., Henzan H., Ohno Y., et al. Influence of transplanted dose of CD56+ cells on development of graft-versus-host disease in patients receiving G-CSF-mobilized peripheral blood progenitor cells from HLA-identical sibling donors. Bone Marrow Transplant 32 (2003) 505-510
37. Savani B.N., Rezvani K., Mielke S., et al. Factors associated with early molecular remission after T cell-depleted allogeneic stem cell transplantation for chronic myelogenous leukemia. Blood 107 (2006) 1688-1695
38. Matthes-Martin S., Lion T., Haas O.A., et al. Lineage-specific chimaerism after stem cell transplantation in children following reduced intensity conditioning: potential predictive value of NK cell chimaerism for late graft rejection. Leukemia 17 (2003) 1934-1942
39. Ottinger H.D., Beelen D.W., Scheulen B., Schaefer U.W., and Grosse-Wilde H. Improved immune reconstitution after allotransplantation of peripheral blood stem cells instead of bone marrow. Blood 88 (1996) 2775-2779